Collegium Pharmaceutical, Inc. (COLL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 37.86 |
| Open | 33.26 |
| Bid | 31.39 x 300 |
| Ask | 31.57 x 100 |
| Day's range | 30.47 - 34.00 |
| 52-week range | 20.83 - 40.95 |
| Volume | |
| Avg. volume | 451,226 |
| Market cap | 1.24B |
| Beta (5Y monthly) | 1.05 |
| PE ratio (TTM) | 24.42 |
| EPS (TTM) | 1.29 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 40.00 |
Simply Wall St.Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) CEO Looks Like They Deserve Their Pay Packet
Key Insights Collegium Pharmaceutical to hold its Annual General Meeting on 16th of May Salary of US$817.0k is part of...
ZacksCollegium Pharmaceutical (COLL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Collegium Pharmaceutical (COLL) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
ZacksCollegium Pharmaceutical (COLL) Q1 Earnings and Revenues Lag Estimates
Collegium Pharmaceutical (COLL) delivered earnings and revenue surprises of -2.68% and 1.44%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.